Parkman Healthcare Partners LLC Profound Medical Corp. Transaction History

Parkman Healthcare Partners LLC

  • $708 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$16.0 - $20.59 $1.35 Million - $1.74 Million
-84,399 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$19.16 - $28.09 $294,106 - $431,181
15,350 Added 22.23%
84,399 $1.7 Million
Q4 2020

Feb 12, 2021
SELL
$16.4 - $22.9 $15,596 - $21,777
-951 Reduced 1.36%
69,049 $1.42 Million
Q3 2020

Nov 13, 2020
BUY
$14.05 - $18.13 $983,500 - $1.27 Million
70,000 New
70,000 $1.24 Million

Others Institutions Holding PROF

# of Institutions
45
Shares Held
8.93M
Call Options Held
1.2K
Put Options Held
5K
View Full List

About Profound Medical Corp.

PROF Quotes by TradingView
  • Ticker PROF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,851,300
  • Market Cap $157M
  • Description
  • Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...
More about PROF
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email